Unlocking B2G Growth: Selling Medical Products to Public Institutions

Unlocking B2G Growth: Selling Medical Products to Public Institutions

Date: 29 October 2026 (Thursday)
Time: 15:30 – 17:00 (Registration starts at 15:15)
Venue: Meeting Point, 7/F, Building 19W, HKSTP

Register Now: LINK

Join us for an insightful sharing session featuring Mr. Anthony Choi, Head of Business at J&K Consulting International Limited.
For medical products and devices startups, entering the public healthcare sector—such as the Hospital Authority (HA)—is a critical milestone for market validation and sustainable expansion. However, navigating strict regulatory compliance, long registration cycles, and public procurement standards requires a clear and structured strategy.

In this session, Anthony will draw on his deep industry expertise across Biotech, Therapeutics, and Healthcare & Life Sciences to explore the practical challenges medical startups face when selling to government and public institutions (B2G). He will examine whether drug registration is truly the only gateway to public hospital doors for Western medicine, highlight why establishing an MDACS compliance identity is essential before approaching the HA, and share tactical guidance on building business-model-fit tailored to public sector procurement.

Whether you are preparing your medical products or devices for HA engagement, building out your regulatory pathway, or exploring B2G growth, this is an invaluable opportunity to gain fresh, actionable insights from an industry expert.
Don’t miss out—secure your spot today and level up your B2G strategy!

Speaker
Mr. Anthony Choi
Head of Business, J&K Consulting International Limited

Anthony Choi is a seasoned business executive and advisor with more than 30 years of experience across biopharma, precision medicine, health-tech, and technology in Asia. His expertise spans commercialization, regulatory affairs, market access, business development, and emerging-market expansion.

He spent 14 years as Head of Business at EVER Neuro Pharma (Asia), leading commercial operations across seven Asian markets and establishing the company’s Myanmar branch. He later served as General Manager of Wango Global, where he oversaw pharmaceutical regulatory compliance in Hong Kong as the designated Person-in-Charge for the Wholesaler Dealer License. At ACT Genomics, he supported the expansion of precision medicine partnerships and commercial opportunities across Asia.

Anthony now serves as Head of Business at J&K Consulting, advising startups and SMEs on government engagement, regulatory strategy, funding, and market entry. He has supported more than 40 technology startups in gaining admission to Cyberport and HKSTP and advised over 200 SMEs and NGOs on government funding programmes.

He brings practical expertise in B2G strategy, regulatory navigation, commercialization, and market expansion across Hong Kong and Southeast Asia.

Anthony holds an MBA from the University of South Australia.

Event Rundown
15:15 – 15:30 Registration
15:30 – 16:15 Sharing Session
16:15 – 16:30 Open Floor Q&A
16:30 – 17:00 Networking